Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SLEEP-IMPROVING PHARMACEUTICAL COMPOSITION CONTAINING RARE GINSENOSIDES RG6 AND F4
Document Type and Number:
WIPO Patent Application WO/2021/213502
Kind Code:
A1
Abstract:
The present invention relates to a sleep-improving pharmaceutical composition containing the rare ginsenosides Rg6 and F4. The pharmaceutical composition of the present invention contains an effective dose of ginsenoside Rg6 and ginsenoside F4 for improving sleep as active ingredients, and a pharmaceutically acceptable carrier. In the present pharmaceutical composition, the mass ratio between the ginsenoside Rg6 and the ginsenoside F4 is 1:1-3:1. On the basis of the present invention, a synergistically interacting rare ginsenoside pharmaceutical composition containing the rare ginsenosides Rg6 and F4 and having a sleep-aiding effect can be provided.

Inventors:
FAN DAIDI (CN)
HUANG RONG (CN)
DUAN ZHIGUANG (CN)
YAN JIANYA (CN)
Application Number:
PCT/CN2021/089324
Publication Date:
October 28, 2021
Filing Date:
April 23, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHAANXI GIANT BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K31/704; A61K45/06; A61P25/20
Foreign References:
CN111358803A2020-07-03
CN103271891A2013-09-04
KR20130001875A2013-01-07
CN104644655A2015-05-27
KR101718355B12017-03-21
KR20120081758A2012-07-20
CN107141332A2017-09-08
Other References:
SHAO JINGJING, ZHENG XIAOYAN, QU LINLIN, ZHANG HUI, YUAN HUIFANG, HUI JUNFENG, MI YU, MA PEI, FAN DAIDI: "Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model", FOOD & FUNCTION, vol. 11, no. 2, 3 February 2020 (2020-02-03), XP055860627, DOI: 10.1039/C9FO02248A
Attorney, Agent or Firm:
BEIJING TANGSONG IP FIRM (CN)
Download PDF: